#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Identification of the First ATRIP–Deficient Patient and Novel Mutations in ATR Define a Clinical Spectrum for ATR–ATRIP Seckel Syndrome


A homozygous mutational change in the Ataxia-Telangiectasia and RAD3 related (ATR) gene was previously reported in two related families displaying Seckel Syndrome (SS). Here, we provide the first identification of a Seckel Syndrome patient with mutations in ATRIP, the gene encoding ATR–Interacting Protein (ATRIP), the partner protein of ATR required for ATR stability and recruitment to the site of DNA damage. The patient has compound heterozygous mutations in ATRIP resulting in reduced ATRIP and ATR expression. A nonsense mutational change in one ATRIP allele results in a C-terminal truncated protein, which impairs ATR–ATRIP interaction; the other allele is abnormally spliced. We additionally describe two further unrelated patients native to the UK with the same novel, heterozygous mutations in ATR, which cause dramatically reduced ATR expression. All patient-derived cells showed defective DNA damage responses that can be attributed to impaired ATR–ATRIP function. Seckel Syndrome is characterised by microcephaly and growth delay, features also displayed by several related disorders including Majewski (microcephalic) osteodysplastic primordial dwarfism (MOPD) type II and Meier-Gorlin Syndrome (MGS). The identification of an ATRIP–deficient patient provides a novel genetic defect for Seckel Syndrome. Coupled with the identification of further ATR–deficient patients, our findings allow a spectrum of clinical features that can be ascribed to the ATR–ATRIP deficient sub-class of Seckel Syndrome. ATR–ATRIP patients are characterised by extremely severe microcephaly and growth delay, microtia (small ears), micrognathia (small and receding chin), and dental crowding. While aberrant bone development was mild in the original ATR–SS patient, some of the patients described here display skeletal abnormalities including, in one patient, small patellae, a feature characteristically observed in Meier-Gorlin Syndrome. Collectively, our analysis exposes an overlapping clinical manifestation between the disorders but allows an expanded spectrum of clinical features for ATR–ATRIP Seckel Syndrome to be defined.


Vyšlo v časopise: Identification of the First ATRIP–Deficient Patient and Novel Mutations in ATR Define a Clinical Spectrum for ATR–ATRIP Seckel Syndrome. PLoS Genet 8(11): e32767. doi:10.1371/journal.pgen.1002945
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1002945

Souhrn

A homozygous mutational change in the Ataxia-Telangiectasia and RAD3 related (ATR) gene was previously reported in two related families displaying Seckel Syndrome (SS). Here, we provide the first identification of a Seckel Syndrome patient with mutations in ATRIP, the gene encoding ATR–Interacting Protein (ATRIP), the partner protein of ATR required for ATR stability and recruitment to the site of DNA damage. The patient has compound heterozygous mutations in ATRIP resulting in reduced ATRIP and ATR expression. A nonsense mutational change in one ATRIP allele results in a C-terminal truncated protein, which impairs ATR–ATRIP interaction; the other allele is abnormally spliced. We additionally describe two further unrelated patients native to the UK with the same novel, heterozygous mutations in ATR, which cause dramatically reduced ATR expression. All patient-derived cells showed defective DNA damage responses that can be attributed to impaired ATR–ATRIP function. Seckel Syndrome is characterised by microcephaly and growth delay, features also displayed by several related disorders including Majewski (microcephalic) osteodysplastic primordial dwarfism (MOPD) type II and Meier-Gorlin Syndrome (MGS). The identification of an ATRIP–deficient patient provides a novel genetic defect for Seckel Syndrome. Coupled with the identification of further ATR–deficient patients, our findings allow a spectrum of clinical features that can be ascribed to the ATR–ATRIP deficient sub-class of Seckel Syndrome. ATR–ATRIP patients are characterised by extremely severe microcephaly and growth delay, microtia (small ears), micrognathia (small and receding chin), and dental crowding. While aberrant bone development was mild in the original ATR–SS patient, some of the patients described here display skeletal abnormalities including, in one patient, small patellae, a feature characteristically observed in Meier-Gorlin Syndrome. Collectively, our analysis exposes an overlapping clinical manifestation between the disorders but allows an expanded spectrum of clinical features for ATR–ATRIP Seckel Syndrome to be defined.


Zdroje

1. MajewskiF, GoeckeT (1982) Studies of microcephalic primordial dwarfism I: approach to a delineation of the Seckel syndrome. Am J Med Genet 12: 7–21.

2. HallJG, FloraC, ScottCIJr, PauliRM, TanakaKI (2004) Majewski osteodysplastic primordial dwarfism type II (MOPD II): natural history and clinical findings. Am J Med Genet A 130: 55–72.

3. GorlinRJ (1992) Microtia, absent patellae, short stature, micrognathia syndrome. J Med Genet 29: 516–517.

4. ThorntonGK, WoodsCG (2009) Primary microcephaly: do all roads lead to Rome? Trends Genet 25: 501–510.

5. GoodshipJ, GillH, CarterJ, JacksonA, SplittM, et al. (2000) Autozygosity mapping of a seckel syndrome locus to chromosome 3q22. 1-q24. Am J Hum Genet 67: 498–503.

6. BorglumAD, BalslevT, HaagerupA, BirkebaekN, BinderupH, et al. (2001) A new locus for Seckel syndrome on chromosome 18p11.31-q11.2. Eur J Hum Genet 9: 753–757.

7. O'DriscollM, Ruiz-PerezVL, WoodsCG, JeggoPA, GoodshipJA (2003) A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome. Nature Genetics 33: 497–501.

8. QvistP, HuertasP, JimenoS, NyegaardM, HassanMJ, et al. (2011) CtIP Mutations Cause Seckel and Jawad Syndromes. PLoS Genet 7: e1002310 doi:10.1371/journal.pgen.1002310.

9. Al-DosariMS, ShaheenR, ColakD, AlkurayaFS (2010) Novel CENPJ mutation causes Seckel syndrome. J Med Genet 47: 411–414.

10. KalayE, YigitG, AslanY, BrownKE, PohlE, et al. (2011) CEP152 is a genome maintenance protein disrupted in Seckel syndrome. Nat Genet 43: 23–26.

11. GriffithE, WalkerS, MartinCA, VagnarelliP, StiffT, et al. (2008) Mutations in pericentrin cause Seckel syndrome with defective ATR–dependent DNA damage signaling. Nat Genet 40: 232–236.

12. RauchA, ThielCT, SchindlerD, WickU, CrowYJ, et al. (2008) Mutations in the pericentrin (PCNT) gene cause primordial dwarfism. Science 319: 816–819.

13. BicknellLS, WalkerS, KlingseisenA, StiffT, LeitchA, et al. (2011) Mutations in ORC1, encoding the largest subunit of the origin recognition complex, cause microcephalic primordial dwarfism resembling Meier-Gorlin syndrome. Nat Genet 43: 350–355.

14. BicknellLS, BongersEM, LeitchA, BrownS, SchootsJ, et al. (2011) Mutations in the pre-replication complex cause Meier-Gorlin syndrome. Nat Genet 43: 356–359.

15. WillemsM, GenevieveD, BorckG, BaumannC, BaujatG, et al. (2010) Molecular analysis of pericentrin gene (PCNT) in a series of 24 Seckel/microcephalic osteodysplastic primordial dwarfism type II (MOPD II) families. Journal of medical genetics 47: 797–802.

16. NamEA, CortezD (2011) ATR signalling: more than meeting at the fork. The Biochemical journal 436: 527–536.

17. ZouL, ElledgeSJ (2003) Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science 300: 1542–1548.

18. CicciaA, ElledgeSJ (2010) The DNA damage response: making it safe to play with knives. Mol Cell 40: 179–204.

19. CortezD, GuntukuS, QinJ, ElledgeSJ (2001) ATR and ATRIP: partners in checkpoint signaling. Science 294: 1713–1716.

20. NamikiY, ZouL (2006) ATRIP associates with replication protein A-coated ssDNA through multiple interactions. Proceedings of the National Academy of Sciences of the United States of America 103: 580–585.

21. BallHL, MyersJS, CortezD (2005) ATRIP binding to replication protein A-single-stranded DNA promotes ATR–ATRIP localization but is dispensable for Chk1 phosphorylation. Molecular biology of the cell 16: 2372–2381.

22. PaciottiV, ClericiM, LucchiniG, LongheseMP (2000) The checkpoint protein Ddc2, functionally related to S. pombe Rad26, interacts with Mec1 and is regulated by Mec1-dependent phosphorylation in budding yeast. Genes Dev 14: 2046–2059.

23. LakinND, JacksonSP (1999) Regulation of p53 in response to DNA damage. Oncogene 18: 7644–7655.

24. WardIM, ChenJ (2001) Histone H2AX is phosphorylated in an ATR–dependent manner in response to replicational stress. J Biol Chem 276: 47759–47762.

25. AldertonGK, JoenjeH, VaronR, BorglumAD, JeggoPA, et al. (2004) Seckel syndrome exhibits cellular features demonstrating defects in the ATR signalling pathway. Human Molecular Genetics 13: 3127–3138.

26. ToledoLI, MurgaM, ZurR, SoriaR, RodriguezA, et al. (2011) A cell-based screen identifies ATR inhibitors with synthetic lethal properties for cancer-associated mutations. Nature structural & molecular biology 18: 721–727.

27. ChanouxRA, YinB, UrtishakKA, AsareA, BassingCH, et al. (2009) ATR and H2AX cooperate in maintaining genome stability under replication stress. The Journal of biological chemistry 284: 5994–6003.

28. AndreassenPR, D'AndreaAD, TaniguchiT (2004) ATR couples FANCD2 monoubiquitination to the DNA damage response. Genes and Development 18: 1958–1963.

29. NoensieEN, DietzHC (2001) A strategy for disease gene identification through nonsense-mediated mRNA decay inhibition. Nature biotechnology 19: 434–439.

30. FalckJ, CoatesJ, JacksonSP (2005) Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. Nature 434: 605–611.

31. KlingseisenA, JacksonAP (2011) Mechanisms and pathways of growth failure in primordial dwarfism. Genes & development 25: 2011–2024.

32. MurgaM, BuntingS, MontanaMF, SoriaR, MuleroF, et al. (2009) A mouse model of ATR–Seckel shows embryonic replicative stress and accelerated aging. Nature genetics 41: 891–898.

33. GuernseyDL, MatsuokaM, JiangH, EvansS, MacgillivrayC, et al. (2011) Mutations in origin recognition complex gene ORC4 cause Meier-Gorlin syndrome. Nat Genet 43: 360–364.

34. de MunnikSA, BicknellLS, AftimosS, Al-AamaJY, van BeverY, et al. (2012) Meier-Gorlin syndrome genotype-phenotype studies: 35 individuals with pre-replication complex gene mutations and 10 without molecular diagnosis. European journal of human genetics : EJHG 20: 598–606.

Štítky
Genetika Reprodukčná medicína

Článok vyšiel v časopise

PLOS Genetics


2012 Číslo 11
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Získaná hemofilie - Povědomí o nemoci a její diagnostika
nový kurz

Eozinofilní granulomatóza s polyangiitidou
Autori: doc. MUDr. Martina Doubková, Ph.D.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#